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Objectives: Bodily distress syndrome (BDS) has been shown to encompass a range of functional somatic 
syndromes (FSS) such as irritable bowel syndrome (IBS), fibromyalgia (FM), and chronic fatigue syndrome 
(CFS) in clinical samples. This study aimed to explore symptom clusters and test classification of individuals 
with illness similar to the BDS criteria in a general population sample. Methods: A stratified subsample of 
1590 individuals from the DanFunD part two cohort was included. Symptoms were assessed with the 
Research Interview for Functional somatic Disorders, performed by trained physicians. In 44 symptoms 
pooled from criteria of IBS, FM, CFS, and BDS, symptom clusters were explored with explorative factor 
analysis. Confirmation of symptom clusters of BDS in the previously described 25- and 30-item BDS 
checklists was performed with confirmatory factor analysis. Classification of individuals into illness groups 
was investigated with latent class analysis. Results: Four symptom clusters (cardiopulmonary, 
gastrointestinal, musculoskeletal, general symptoms/fatigue) corresponding to the BDS subtypes and their 
corresponding FSS were identified and confirmed. A three-class model including 25 BDS items had the best 
fit for dividing participants into classes of illness: One class with low probability, one class with medium 
probability, and one class with high probability of having ≥4 symptoms in all symptom clusters.    
Conclusion: The BDS concept was confirmed in the general population and constitutes a promising 
approach for improved FSS classification. It is highly clinical relevant being the only diagnostic construct 
defining the complex multi-organ type. 
 
 
Key words: Bodily distress syndrome, factor analysis, functional somatic disorders,  latent class analysis, 














Persistent physical symptoms are prevalent in general populations and medical settings (1,2). When severe, 
such symptoms are often disabling for individuals and costly for society (2).  
Within the various medical specialties, the classification and delimitation of conditions characterized by 
persistent physical symptoms that cannot be assessed with clinical or paraclinical tests have shown to be 
inconsistent: Within the general medicine tradition, they are addressed as e.g. non-cardiac chest pain 
(cardiology), irritable bowel syndrome (IBS) (gastroenterology), fibromyalgia (FM) (rheumatology), and 
chronic fatigue syndrome (CFS) (infectious diseases); diagnoses that are often summarized under the label 
functional somatic syndromes (FSS) (3). Within psychiatry, these syndromes are mainly covered by the 
somatoform disorder diagnoses (SFD) defined by the World Health Organization International Classification 
of Diseases (ICD)-10, or by somatic symptom disorder (SSD) defined in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM)-5 (2,4-6). Studies have shown a great overlap of these different 
diagnoses indicating that they may belong to the same family of disorders instead of being distinct entities 
(3,4,6,7). To accommodate this, the diagnostic construct, bodily distress syndrome (BDS), was developed in 
a sample of primary care patients and patients from neurological and internal medicine departments (4,7). 
Here, symptoms were assessed with a modified version of Schedules of Clinical Assessment in 
Neuropsychiatry (SCAN) (8). BDS consists of four symptom clusters; a cardiopulmonary (CP) cluster, a 
gastrointestinal (GI) cluster, a musculoskeletal (MS) cluster, and a general symptoms/fatigue (GS) cluster. It 
comprises a single/oligo-organ type, i.e. ≥3 symptoms from one or two of the symptom clusters or ≥4 
symptoms across symptom clusters, and a multi-organ subtype, i.e. having ≥3 symptoms from at least three 
of the symptom clusters (4,7). BDS thus comprises a unifying concept, i.e. it eliminates the problematic 
overlaps of the medical specialty-specific FSS by identifying both a distinct multi-organ type and a 
single/oligo-organ type depending on number of affected organ systems in the patient. The BDS construct 
has been verified in a primary care sample where cases were assessed with self-reported patient 
questionnaires (5,9). This analysis confirmed the symptom clusters as well as the single/oligo-organ type; 













reported symptoms across symptom clusters, and the multi-organ subtype defined as having ≥4 self-reported 
symptoms from at least three of the symptom clusters. Unlike the SFD and the SSD but in accordance with 
the various definitions for FSS, no emotional or behavioral symptoms are part of the diagnostic criteria. 
 
BDS has shown to be prevalent in different settings in Denmark (7,10-12) and to encompass a great part of 
the present diagnostic constructs, both within selected patient samples (7,13) and in the general population 
(10). Further, the European research network EURONET-SOMA has drafted the term functional somatic 
disorders (FSD) as an umbrella classification of the various FSS and BDS (14). BDS has showed to be 
applicable in different settings, and an adapted version of the diagnosis, bodily stress disorder, has been 
included in the primary care version of the ICD-11 draft for the mental disorder chapter (15) and included in 
primary care studies (16,17). Of note, the bodily stress disorder diagnosis uses only the terminology of the 
BDS concept but has different diagnostic criteria.  
To date, the diagnostic construct of BDS has not yet been scientifically verified in the general population. 
This is a further necessary step in finally accepting BDS as a diagnostic construct (18). 
This study was based on a stratified subsample from the adult Danish population and aimed to 1) explore 
symptom clusters in symptoms pooled from criteria of IBS, FM, CFS, as well as BDS, 2) confirm established 
symptom clusters of BDS in symptom lists equivalent to the 25- and 30-item BDS checklists (9), and 3) 
investigate the classification of individuals as to the BDS criteria. 
The following hypotheses were made: 1) Symptom clusters consistent with subtypes of BDS and the 
corresponding FSS would reveal in symptoms pooled from criteria of IBS, FM, CFS, and BDS, 2) symptom 
clusters from the previously described 25- and 30-item BDS checklists would be confirmed, and 3). 














2.1. Participants and data collection 
We included a stratified subsample from the Danish Study of Functional Disorders (DanFunD) part two 
cohort (n=7493) (19) (Fig 1). Participants filled in questionnaires with measures of BDS and health anxiety, 
among others. Every tenth participant together with all high scores on the BDS checklist (9) or Whiteley-7 
scale (20) were invited to participate in a diagnostic interview (n=2450). A total of 1590 (64.9%) participants 
agreed to participate and were included in the study. Of those, 796 were high scores and 794 were randomly 
selected of whom 187 also showed to be high scores. 
Figure 1 around here 
2.2. Measurements 
Symptoms were assessed with the newly developed Research Interview for Functional somatic Disorders 
(RIFD), a semi-structured interview originally developed from the modified version of SCAN for use in 
epidemiological research (21). Interviews were conducted by telephone, and all interviewers were family 
physicians trained in conducting both SCAN and RIFD.  
Of relevance for this study, RIFD included symptoms for assessing three common FSS: IBS (22), FM (23), 
and CFS (24), together with symptoms defining BDS (7,9). The interviewer had the possibility to state 
whether a whole symptom cluster  could be explained by other organic conditions or if it was part of a FSD. 
All items were dichotomous. Some of the symptoms for FSS and BDS were identically or almost identically 
named. A correlation matrix was performed, and answers from identically named items and items with a 
correlation above 0.75 were collapsed and analyzed as one item. We collapsed the answers for 26 items. 
Thus, in total, we included 44 symptoms pooled from criteria of IBS, FM, CFS, and BDS (Appendix A).  
2.3. Analyses 
Basic statistical analyses were performed with Stata 15.0 for Windows (25). Age and sex were compared 
between the high score group and the randomly selected group with a two-sample t-test and χ2-test, 













scores were excluded. Factor analyses and latent class analysis (LCA) were performed in Mplus version 8.0 
(26). 
2.3.1. Exploring symptom clusters in symptoms of IBS, FM, CFS, and BDS 
Exploratory factor analysis (EFA) with oblique Geomin rotation and WLSMV
1
 estimation (26) was applied 
on all 44 dichotomous items. The number of factors in the EFA was determined by the number of 
eigenvalues above one, at least three items with high loadings on the respective factor, and potentials for the 
models to be interpretable and render clinical meaning. Indicators of a good model fit were a Root Mean 
Square Error of Approximation (RMSEA) <0.05, a Comparative fit Index (CFI) and a Tucker-Lewis fit 
Index (TLI) >0.95, and a Standardized Root Mean square Residual (SRMR) <0.08 (27). Values of the χ
2
-test 
were also reported, but as this may tend to be sensitive to sample size, model fit values from this test were 
not taken into consideration in the final model fit assessment (28). 
 
2.3.2. Can we confirm established symptom clusters of BDS?  
In order to confirm the four BDS symptom clusters established in different medical settings, two 
confirmatory factor analyses (CFA) with WLSMV
1
 estimation (26) were performed: One CFA on the 30-
item BDS checklist derived from the original work by Fink et al. (4) and one CFA on the 25-item BDS 
checklist from the additional work by Budtz-Lilly et al. (9).  
Indicators of good fit to the models were a RMSEA <0.05, a CFI and TLI >0.95, and a SRMR <0.08 (27). 
2.3.3. Classification of individuals into illness groups similar to the BDS criteria  
Four different LCAs with WLSMV
1
 estimation (26) were performed. They all included five dichotomous 
variables derived from the symptom four clusters of BDS  and one group with ≥4 symptoms across all 
symptom clusters. In the first model, we included the BDS criteria by Budtz-Lilly et al. (≥4 symptoms in a 
cluster and ≥4 symptoms across clusters) (9) on 25 items. In a second model, we included the BDS criteria 
by Fink et al. (≥3 symptoms in a cluster and ≥4 symptoms across clusters) (4) on 30 items. In a third model, 
                                        
1 Weighted least square parameter estimates using a diagonal weight matrix with standard errors and mean 













we included the BDS criteria by Budtz-Lilly et al. (≥4 symptoms in a cluster and ≥4 symptoms across 
clusters) (9) on all 44 items. In a fourth model, we included the BDS criteria by Fink et al. (≥3 symptoms in a 
cluster and ≥4 symptoms across clusters) (4) on all 44 items.  
All models were evaluated by several model fit statistics (28,29). For information criteria, Akaike's 
Information Criteria (AIC), the Bayesian Information Criteria (BIC), the Sample-size estimated BIC, the 
Consistent AIC (CAIC), and the Approximated Weight of Evidence (AWE) were used. For all these 
measures, the lowest value indicates the optimal number of classes. Also, Chi-Square fit statistics for binary 
data were used to evaluate the overall fit of the models. A Chi-square P-value above 0.05 indicated an 
acceptable fit. Entropy was used to evaluate the model's capacity to separate individuals into classes. An 
entropy above 0.8 indicated an acceptable separation (30). Finally, the models were evaluated on their 
clinical interpretation and the management and transparency of class assignment.  
2.3.4. Subanalyses  
EFA were performed within each subgroup of participants, (randomly selected individuals and high scores). 
The 187 participants that were randomly selected but also showed to be high scores were included and 
analyzed with both subgroups.  
EFA, CFA and LCA were performed 1) within each sex and 2) only including symptoms that could not be 
better explained by other organic conditions. 
2.4. Ethical considerations 
Written informed consent was obtained from each participant before participation in the study. The study 
was approved by the Ethical Committee of Copenhagen County (Ethics Committee: KA-2006-0011; H-3-
2011-081; H-3-2012-0015) and the Danish Data Protection Agency. 
3. Results 
The mean age of the 1590 participants was 51.9 years (SD: 13.1); 59.3% were women. Prevalence of each 













were found between the two subgroups according to age (t(1401)=-0.64, p=0.53), but there were 
significantly more women in the high score group compared to the group of randomly selected individuals 
(64.5% vs. 48.9%, χ
2
(1)=34.0, p<0.0001). 
3.1. Exploring symptom clusters in symptoms of IBS, FM, CFS, and BDS 
In the EFA, seven eigenvalues greater than one and a model with five factors including at least three distinct 
items with loadings ≥0.5 was revealed (Appendix B). 
The items regurgitations, burning sensation in the chest or upper part of the stomach/epigastrium and 
heartburn loaded ≥0.5 on both a fifth factor characterizing an upper GI factor and a factor with the other 
gastrointestinal items. Hence, it was reasonable to conclude that a four-factor model characterized by CP 
symptoms, GI symptoms, MS symptoms, and GS/fatigue symptoms as in the original studies on BDS also 
applied here (Table 1). In both models, the items regurgitations and heartburn were difficult to place; they 
loaded ≥0.5 in more than one factor. Factor correlations between factors in the four-factor model ranged 
from 0.36 to 0.52.  
Table 1 around here 
3.2. Can we confirm established symptom clusters of BDS? 
Both original four-factor models of BDS were confirmed with good fit to the observed model (Table 2).  
Table 2 around here 
3.3. Classifications of individuals into illness groups similar to the BDS criteria 
The LCA applied on a pool of 25 symptoms and BDS criteria by Budtz-Lilly et al. (9) revealed a three-class 
model with acceptable capacity of classification (Entropy=0.95) and model fit (χ
2
(14)=16.3, p=0.30). It 
constituted one class with 0% probability of having ≥4 symptoms in any symptom cluster, one class with 8-
45% probability of having ≥4 symptoms in all symptom clusters, and one class with 63-89% probability of 
having ≥4 symptoms in all symptom clusters. The two latter classes also had 100% probability of fulfilling 













The LCA applied on a pool of 30 symptoms and BDS criteria by Fink et al. (4) also showed a three-class 
model. The model constituted one class with 0-7% probability of having ≥3 symptoms in any symptom 
cluster, one class with 17-62% probability of having ≥3 symptoms in all symptom clusters, and one class 
with 73-100% probability of having ≥3 symptoms in all symptom clusters. The two latter classes had 100% 
probability of fulfilling the criteria ≥4 symptoms across clusters (Fig 2B). Classification capacity was high 
(Entropy= 0.948), however, the model fit was not acceptable (χ
2
(14)=39.6, p=0.0003).  
 
Figure 2 around here 
 
Two additional LCA were performed on all 44 items. The first model included the BDS criteria by Budtz-
Lilly et al. (9) (4 symptoms within a cluster and ≥4 symptoms across clusters). This model revealed a four-
class solution consisting of one class with 0% probability of having ≥4 symptoms in any symptom cluster 
(class size: 39.6%) and one class with 57-97% probability of having ≥4 symptoms in all symptom clusters 
(class size: 8.6%). The two other classes constituted one class with 12-48% probability of having ≥4 
symptoms in all symptom clusters (class size: 32.8%) and one class primarily characterized by 100% 
probability of having ≥4 symptoms in the MS cluster (class size: 18.9%). The three latter classes also had 
100% probability of fulfilling the criteria of ≥4 symptoms across clusters. This model had an acceptable 
model fit (χ
2
(8)=7.32, p=0.50) but lacked classification capacity (Entropy=0.78).  
The second model included the BDS criteria by Fink et al. (4). This model also revealed a four-class solution 
consisting of one class with 0-6% probability of having ≥3 symptoms in any symptom cluster (class size: 
39.6%) and one class with 39-78% probability of having ≥3 symptoms in all symptom clusters (class size: 
32.4%). The two other classes constituted one class primarily characterized by 94% probability of having ≥3 
symptoms in the MS cluster (class size: 20.3%) and one class primarily characterized by 100% probability of 
having ≥3 symptoms in the GI cluster (class size: 7.7%). The three latter classes also had 100% probability 
of fulfilling the criteria of ≥4 symptoms across clusters. This model had a poor model fit (χ
2
(8)=25.2, 













From these LCAs and the clinical interpretation and size of each class, we found the most suitable model to 
be the model including 25 symptoms and criteria by Budtz-Lilly et al. (9). This model constituted three 
classes of individuals that differ on several characteristics, indicating different disease load (Table 3). 
Table 3 around here 
3.4. Subanalyses 
None of the results from the subanalyses led to questioning of the results from the main analyses on the 
whole sample, and it could be concluded that these results were not due to participants selection (Appendix 
C), sex (Appendix D) or symptom etiology (Appendix E). 
4. Discussion 
4.1. Principal findings 
We studied 44 symptoms pooled from criteria of IBS, FM, CFS, and BDS. By means of EFA, we identified 
four symptom clusters: A CP cluster, a GI cluster, a MS cluster, and a GS cluster. The four-factor models of 
BDS were furthermore confirmed whether using the previous reported 25-item BDS symptom checklist (9) 
or the 30-item BDS symptom checklist (4).  
The best fitting model for dividing participants into different classes of illness was the model by Budtz-Lilly 
et al. (9). In an LCA including 25 symptoms corresponding to the 25-items BDS symptom checklist (9), 
participants were divided into three classes that, after clinical interpretation, could be understood as one class 
with healthy participants (i.e. no BDS), one class with single/oligo-organ BDS, and finally, a class with 
multi-organ BDS.  
4.2. Comparison with existing literature 
The identified four-factor model of symptom clusters from the current study has been found independently of 
assessment method both in studies including patient samples (4,5,7,9,31-34) and studies including unselected 













In accordance with the present study, previous studies in clinical patient samples have also shown that these 
symptom clusters can be used for a diagnostic classification, dividing individuals into three different classes 
of illness (4,5,7,9). We found the same four symptom factors and the same three LCA classes as the original 
studies by Fink et al. (4) and Budtz-Lilly et al. (9), both in our main analysis including all symptoms 
regardless of etiology and in our subanalysis only including symptoms that could not be attributed to other 
medical conditions. However, studies from other research groups are inconsistent in how to define 
individuals with or without illness. In a population-based study of 964 individuals, Rosmalen et al. (36) 
concluded on the basis of four LCAs that a two-class model had the best fit for dividing individuals into 
classes of illness. However, they based the LCAs on the 23 most prevalent and non-gender specific 
symptoms and one of their primary aims was to test if a symptom count and a cut-off could be used for a 
categorical diagnosis of somatization. Hence, their aims and therefore interpretation of results may not be 
comparable to our study. In a primary care study on multi-somatoform disorders by Kroenke et al. (37), they 
identified three symptom clusters of MS/fatigue, GI, and CP by EFA in a 13-symptom checklist which is 
similar to our results. However, they recommended a simple symptom count for differentiating between 
groups with and without illness. A cut-off of seven symptoms was made, however this was not based on 
LCA methods but on calculation of sensitivity, specificity, and predictive values of various symptom 
thresholds for multi-somatoform disorders. Finally, in a study by Lacourt et al. (38) including 394 
individuals with reported functional somatic symptoms, cluster analysis was used on 47 items, exploring 
three cluster solutions. This study identified the same four symptom clusters as in the current study, and 
these clusters differed on total symptom score. They found the solution, dividing individuals into two 
clusters of illness, to have the best fit. However, their sample size was small and they chose the two-cluster 
solution on the basis of its discriminative ability.   
Our results from the LCA including all 44 symptoms indicate that when establishing a simple symptom 
count cut-off, the number of symptoms has to be taken into account; the more symptoms included, the lower 
the probability gets of falling into classes presumably interpreted as "healthy". This is underlined by our 
results where the size of the class with low probability of having ≥4 symptoms in any of the symptom 













defined symptom checklist may be practical in large-scale epidemiological studies where distinction between 
"disease" and "no disease" is sought, but it may be of little value in clinical practice for diagnosing patients 
with FSD. Here, a symptom pattern recognition such as the BDS construct may be more appropriate (5).  
Other studies on large population-based samples where the group of individuals with severe disease is large 
enough to be detected, support our classification of individuals (39-41). These studies, one of them 
conducted on the whole DanFunD baseline cohort (39), identified one class with no symptoms, multiple 
classes with few, specific symptoms, and one class with all symptoms. Hence, even though these studies 
identify a larger number of classes than in the current study, their results do not conflict with ours but may be 
attributed to methodological differences: All have used LCA on obtained symptoms contrary to the current 
study in which we have used the information from the factor analyses on symptom clustering into organ 
systems. Using only five dichotomous variables in the LCAs may have limited the number of classes that 
could be estimated, and this may account for the difference in obtained number of classes compared to the 
other studies. From a clinical point of view a simpler model with fewer classes may be more applicable to 
differentiate between patients and their management.  
4.3. Strengths and limitations 
A major strength of the current study is the large sample of 1590 participants who completed the interview. 
Furthermore, symptoms were obtained through clinical diagnostic interviews performed by family 
physicians that were all trained in conducting the specific interview. This ensured valid presence of each 
symptom. Also, the included sample was drawn from a large Danish general population sample, making it 
less prone to selection bias than the patient samples in which BDS until now has been investigated (4,7,9). 
Finally, we addressed recent symptoms that had been present within the last 12 months, which may have 
reduced the risk of recall bias compared to using life-long symptoms (42,43).  
However, some limitations also need to be addressed: First, we included a stratified subsample why a risk of 
selection bias cannot be excluded. However, as we did not obtain any major difference by analysing 
subgroups, nothing indicated that this stratification has influenced the results. Second, we included all 













symptoms that could not be better explained by other organic conditions. Third, our data included a high 
number of symptoms (n=44) relative to a rather small sample (n=1590), and therefore we could not include 
individual symptoms in the LCA which limits direct comparison with other studies (9,36,39-41). Fourth, the 
different analyses were depending on the input of symptoms and criteria. Thus, there may be other important 
symptom clusters that were not detected in the current study, e.g. urogenital or temporomandibular/jaw 
clusters (4). Even though our classes from the LCAs differed in number of fulfilled criteria rather than type 
of specific criteria, including additional symptom factors might have increased the number of classes in the 
LCAs.  
4.4. Clinical implications 
Our study provides further empirical support of the clustering of symptoms into a CP type, a GI type, an MS 
type, and a GS/fatigue type as defined by the BDS criteria. We have further shown that symptoms of IBS, 
FM, and CFS were aligned in the same symptom specific clusters as the BDS clusters. This supports studies 
on BDS and the previous findings that BDS as a unifying construct may encompass the various FSS (4,7,10). 
From a clinical as well as a research point of view, this indicates that the BDS concept may be used instead 
of the several specialty-specific FSS, making it easier to communicate between medical specialties and 
clinical management. Furthermore, the current verification of the BDS concept in a sample from an 
unselected general population supports that BDS  is not an artefact of medical specialization.  
In a previous study, we have argued that the BDS construct provides the opportunity of distinguishing 
between mono- and multi-syndromatic individuals which may be of paramount importance  in clinical 
management as the latter group constitute complex patients  with severe need of treatment.  This group is not 
delamitated and may be neglected in current approach the various FSS categories induce  (10,44). The 
current study and its results support the diagnostic construct of BDS and its use in not only selected patient 
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Figure 1:  
Figure legend: Flow of study participants.  




Figure 2:  
Figure legend: Conditional probabilities of individuals fulfilling criteria of bodily distress 
syndrome given class.  
Figure captions: A: Analyses including the bodily distress syndrome (BDS) criteria by Budtz-Lilly et al. (9) 
made on 25 items. B: Analyses including the BDS criteria by Fink et al. (4) made on 30 items. Vertical axis: 
Probabilities of individuals in the respective class to fulfill the criteria stated in the horizontal axis. 
Percentages stated after each class report size of the class. Abbreviations: BDS=bodily distress syndrome; 
CP=cardiopulmonary; GI=gastrointestinal; MS=musculoskeletal; GS=general symptoms/fatigue; 4 symp. 




































































Table 1: Exploratory factor analysis with oblique geomin rotation on 44 symptoms 
(n=1590) 
    Factor 1 Factor 2 Factor 3 Factor 4 
 
Cardiopulmonary symptoms (CP) 
Palpitations or heart pounding 0.91 <-0.00 -0.08 0.03 
Precordial discomfort 0.90 -0.03 -0.12 0.06 
Breathlessness without exertion 0.82 -0.10 -0.07 0.11 
Hyperventilation 0.81 -0.04 0.02 -0.01 
Hot or cold sweats 0.74 0.02 0.04 0.15 
Trembling or shaking 0.72 0.03 -0.09 0.27 
Dry mouth 0.65 -0.03 0.09 0.21 
Churning in stomach 0.65 0.18 -0.15 0.24 
Flushing or blushing 0.57 0.14 0.07 0.14 
 
Gastrointestinal symptoms (GI) 
Frequent, loose bowel movements -0.07 0.96 -0.05 0.03 
Diarrhea -0.09 0.94 -0.17 0.07 
Abdominal pain 0.03 0.86 -0.07 0.09 
Feeling bloated, full of gas, distended/Distension 0.03 0.88 -0.06 0.11 
Regurgitations 0.60 0.69 0.04 -0.40 
Altering stool form -0.05 0.90 0.01 0.03 
Nausea 0.08 0.53 0.00 0.27 
Vomiting -0.01 0.40 0.07 0.19 
Burning sensation in the chest or upper part of the 
stomach/epigastrium 0.38 0.63 0.11 -0.22 
Borborygmi 0.06 0.85 -0.08 0.09 
Heartburn 0.62 0.65 0.07 -0.45 
Musculoskeletal symptoms (MS) 
Pain in arms or legs -0.01 <-0.00 0.99 <0.00 
Muscular aches or pains <0.00 <0.00 0.82 0.15 
Joint pain 0.09 0.05 0.85 -0.08 
Feeling of paresis in arms or legs 0.01 -0.23 0.66 0.21 
Pain moving from one place to another 0.05 0.08 0.62 0.06 
Unpleasant numbness or tingling sensations -0.01 0.09 0.68 0.18 
Back ache/Pain in chest or back 0.07 <0.00 0.63 0.17 
Pain in muscles, bones or joints lasting at least one 
week -0.02 0.01 0.94 0.01 
Pain in shoulders, arms or hands 0.05 <0.00 0.83 0.09 
Pain in legs or feet 0.05 <-0.00 0.88 -0.06 
Pain in the neck -0.07 0.05 0.45 0.32 
 
General symptoms (GS) 
Headache 0.11 0.13 0.09 0.52 
Dizziness 0.24 0.09 0.08 0.46 
Concentration difficulties/Difficulties concentration 0.15 0.02 <0.00 0.85 
Fatigue/Problems with tiredness 0.14 0.05 0.07 0.87 
Memory difficulties/Memory difficulties 0.15 -0.05 0.02 0.86 
Need to rest more  0.11 0.04 0.06 0.86 
Feel sleepy or drowsy  0.07 0.06 0.03 0.87 
Problems starting things 0.04 0.04 0.08 0.86 
Lack of energy 0.04 0.02 0.10 0.89 
Less strength in muscles -0.13 -0.02 0.29 0.85 
Feel weak -0.07 <0.00 0.25 0.85 
Make slips of the tongue when speaking 0.04 0.01 <-0.00 0.91 
Difficulties finding the right words 0.04 0.02 -0.02 0.90 
     
Factor loadings >0.3 are shown in bold.  
Factor (F) correlations: F1 and F2: 0.43; F1 and F3: 0.42; F1 and F4: 0.52; F2 and F3: 0.36; F2 and F4: 0.46; F3 and F4: 0.40.  
Tests of model fit: Root Mean Square Error of Approximation=0.05; Comparative fit Index=0.99, Tucker-Lewis fit  Index=0.99, Standardized Root 
Mean square Residual=0.05. 














Table 2: Goodness of fit parameters from the confirmatory factor analyses  
Model RMSEA 95% CI CFI TLI SRMR X2 df p 
         
BDS a, Budtz-Lilly et al (9) 0.039 0.036 0.042 0.978 0.975 0.069 922.245 269 <0.0001 
BDS b, Fink et al (4) 0.034 0.032 0.036 0.978 0.977 0.073 1130.37 399 <0.0001 
          
Abbreviations: RMSEA=Root Mean Square Error of Approximation; CI=Confidence Interval; CFI=Comparative Fit Index; TLI=Tucker -lewis fit  
Index; χ
2
=Likelyhood Ratio Test; df=degrees of freedom, p=p-value.  
Bold: Indicates a good fit  between the specified model and the observed model in the data. 
Factor (F) correlations: 
a
F1 and F2: 0.51; F1 and F3: 0.49; F1 and F4: 0.64; F2 and F3: 0.42; F2 and F4: 0.57; F3 and F4: 0.57.  
b
F1 and F2: 0.55; F1 




F1: 0.80-0.89; F2: 0.79-0.92; F3: 0.65-0.94; F4: 0.75-0.97. 
b














Table 3: Characteristics of individuals in classes from the latent class analysis on 25 items and criteria of having 
≥4 symptoms in a symptom cluster or ≥4 across symptom clusters  
 Class 1 Class 2 Class 3 
    
Class size; n (%) 814 (51.2) 732 (45.4) 44 (3.4) 
Weighted prevalencea; % (95% CI) 73.6 (71.1-75.9) 25.0 (22.7-27.5) 1.4 (1.0-2.0) 
    
Women; % 51.2 67.1 77.3 
    
Age; mean (SD) 52.3 (13.2) 51.4 (13.0) 53.1 (12.0) 
    
Self-perceived healthb; %    
Poor  6.5 38.9 52.3 
Good 93.1 60.7 45.5 
NA 0.4 0.4 2.3 
    
Impaired by symptomsc, % 2.8 33.9 77.3 
NA 83.8 27.2 4.6 
    
Years with symptomsc; median (IQR) 0 (0-2) 6 (1-18) 14 (5-21) 
NA 90.4 44.0 11.4 
    
Physical comorbidityd; % 42.0 80.9 75.0 
NA 0 0 0 
    
Mental comorbiditye; % 2.8 15.4 36.4 
NA 0 0 0 
    
a 
Prevalence of each class weighed back to the whole DanFunD sample 
b
 One self-reported question from the 12-item Short Form Health Survey (30) 
c
 A global assessment through the interview (20) 
d
 Assessed through the interview: At least one of the following: Diabetes, asthma, joint disease, heart disease, hypertension, pulmonary disease, other 
conventionally-defined physical condition (20) 
e
Assessed through the interview: At least one of the following: Major depressive disorder from the 10th International Classification of Disease (31), 
panic attacks, social phobia, generalized anxiety (20) 
















 The Bodily distress syndrome (BDS) construct can be used in general populations  
 Four symptom clusters corresponding to the BDS subtypes were identified and confirmed  
 Participants were divided into three classes of illness severity 
 BDS constitutes a promising approach for classification of functional somatic disorders 
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